126 related articles for article (PubMed ID: 25665313)
1. [Bladder cancer and urothelial tumors. New therapeutic strategies].
Desgrandchamps F; Hennequin C; Culine S
Rev Prat; 2014 Dec; 64(10):1363-4. PubMed ID: 25665313
[No Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer.
Herr HW
Eur Urol; 2009 Feb; 55(2):303-5; discussion 305-6. PubMed ID: 18995950
[No Abstract] [Full Text] [Related]
3. Comparative study of conventional urothelial carcinoma, squamous differentiation carcinoma and pure squamous carcinoma in patients with invasive bladder tumors.
Gluck G; Hortopan M; Stănculeanu D; Chiriță M; Stoica R; Sinescu I
J Med Life; 2014 Jun; 7(2):211-4. PubMed ID: 25408727
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
[TBL] [Abstract][Full Text] [Related]
5. [Recommendations Onco-Urology 2010: Urothelial tumors].
Pfister C; Roupret M; Wallerand H; Davin JL; Quintens H; Guy L; Houede N; Bernardini S; Larré S; Mazerolles C; Roy C; Amsellem D; Saint F; Irani J; Soulié M;
Prog Urol; 2010 Nov; 20 Suppl 4():S255-74. PubMed ID: 21129645
[No Abstract] [Full Text] [Related]
6. Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen.
Azuma H; Inamoto T; Takahara K; Ibuki N; Nomi H; Yamamoto K; Narumi Y; Ubai T
Int J Urol; 2012 Jan; 19(1):26-38. PubMed ID: 22077821
[TBL] [Abstract][Full Text] [Related]
7. Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy.
Canter D; Viterbo R; Kutikov A; Wong YN; Plimack E; Zhu F; Oblaczynski M; Berberian R; Chen DY; Greenberg RE; Uzzo RG; Boorjian SA
Urology; 2011 Jan; 77(1):160-5. PubMed ID: 20709369
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid urothelial carcinoma of the bladder: a rare malignancy.
Philippou P; Kariotis I; Volanis D; Ploumides A; Delakas D
Urol Int; 2011; 86(3):370-2. PubMed ID: 21325783
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant cisplatin chemotherapy and radical cystectomy in bladder carcinoma].
Dunst J
Strahlenther Onkol; 1996 Aug; 172(8):463-4. PubMed ID: 8765352
[No Abstract] [Full Text] [Related]
10. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of bladder cancer.
Sharma S; Ksheersagar P; Sharma P
Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer.
Barocas DA; Clark PE
Curr Opin Oncol; 2008 May; 20(3):307-14. PubMed ID: 18391631
[TBL] [Abstract][Full Text] [Related]
13. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
[TBL] [Abstract][Full Text] [Related]
14. [Infiltrating cancer of the bladder: can radiochemotherapy be an alternative to cystectomy?].
Chrétien Y; Mejean A; Durdux C; Dufour B; Housset M
J Urol (Paris); 1996; 102(1):3-8. PubMed ID: 8763598
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment.
O'Donnell PH; Posadas EM
Urology; 2011 Jan; 77(1):165-6. PubMed ID: 21195839
[No Abstract] [Full Text] [Related]
16. Bladder cancer.
Clark PE
Curr Opin Oncol; 2007 May; 19(3):241-7. PubMed ID: 17414643
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
18. Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approaches.
Galsky MD; Domingo-Domenech J
Clin Adv Hematol Oncol; 2013 Feb; 11(2):86-92. PubMed ID: 23598909
[TBL] [Abstract][Full Text] [Related]
19. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
20. [Case of small cell carcinoma of the urinary bladder effectively treated with adjuvant chemotherapy and radiotherapy following TUR].
Okuda Y; Mori Y; Katoh Y; Iguchi M; Katoh M; Yamazaki D
Hinyokika Kiyo; 2009 May; 55(5):267-9. PubMed ID: 19507545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
